-
公开(公告)号:DE59209745D1
公开(公告)日:1999-10-21
申请号:DE59209745
申请日:1992-11-23
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER , MUELLNER STEFAN , BREIPOHL GERHARD
IPC: A61K38/28 , A61K38/00 , A61P3/08 , A61P3/10 , C07K5/06 , C07K5/065 , C07K5/08 , C07K5/087 , C07K5/093 , C07K5/097 , C07K7/06 , C07K7/08 , C07K9/00
Abstract: Peptides with insulin-like activity and the formula I where C is a hydrogen atom, amino-acid residue, substituted amino-acid residue or sugar residue, D is an amino-acid residue, phosphoamino-acid residue, sugar residue, covalent bond or hydroxyl radical, E is a hydrogen atom, hydroxyl radical, substituted sugar residues, substituted alkyldiamine or glycerol residue, R is (C1-C4)-alkyl, =O or -O-(C1-C4)-alkyl, R is a sulphur protective group, SO2, SO3, (C1-C3)-alkyl, O2 radical, O3 radical, or hydrogen atom, R or R is, independently of one another, hydrogen or methyl, and W is an integer 1 or 2, the preparation and use thereof for the treatment of diabetes mellitus or non-insulin-dependent diabetes are described.
-
公开(公告)号:HK1008786A1
公开(公告)日:1999-05-21
申请号:HK98109588
申请日:1998-07-31
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER
IPC: C07H15/207 , A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/715 , A61K31/716 , A61K38/28 , A61P3/08 , A61P3/10 , A61P5/00 , A61P5/48 , C07H3/04 , C07H3/06 , C07H11/04 , C07H15/203 , C08B37/00 , C07H , A61K
Abstract: Inositol glycan derivatives of formula (I), their salts and stereoisomeric forms, are new: A-Z-R (I) A = HP(=O)(OH), HP(=S)(OH), HOP(=S)(OH), HSP(=S)(OH), (1-4C alkyl)P(=O)(OH), (1-4C alkyl)P(=S)(OH), SO2ORl, S(=O)OR1, NH2CO, NR1R2, R1R2NCONH, R1OSO2NH, (1-4C alkyl)SO2, (1-4C alkyl)S(=O) or R1S; R1, R2 = H or 1-4C alkyl; Z = 2-6 sugar residues (optionally substituted by up to 6 Me, sugar residue, di-sugar residue, SO2OH, CONR1R2, CO(1-4C alkyl), P(=O)(H)OH, P(=O)(OH)2, P(=S)(H)OH, P(=S)(OH)2, P(=S)(SH)(OH), P(=O)(OH)OCH2CH2NR1R2), or the glycosidic bridge between the 2-6 sugar residues may be 1-6 fold replaced by CH2 or S; R = inositol, inositol phosphate, inositol thiophosphate, inositol cyclo-phosphate, inositol cyclo-thiophosphate (optionally substituted by 1-2 phosphate or thiophosphate, or single substitution by cyclo-phosphate or cyclo-thiophosphate), or inositol (where two neighbouring OH groups are replaced by CH2SO2NH).
-
公开(公告)号:PL323407A1
公开(公告)日:1998-06-08
申请号:PL32340797
申请日:1997-11-28
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER
IPC: C07H15/207 , A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/715 , A61K31/716 , A61K38/28 , A61P3/08 , A61P3/10 , A61P5/00 , A61P5/48 , C07H3/04 , C07H3/06 , C07H11/04 , C07H15/203 , C08B37/00
Abstract: Inositol glycan derivatives of formula (I), their salts and stereoisomeric forms, are new: A-Z-R (I) A = HP(=O)(OH), HP(=S)(OH), HOP(=S)(OH), HSP(=S)(OH), (1-4C alkyl)P(=O)(OH), (1-4C alkyl)P(=S)(OH), SO2ORl, S(=O)OR1, NH2CO, NR1R2, R1R2NCONH, R1OSO2NH, (1-4C alkyl)SO2, (1-4C alkyl)S(=O) or R1S; R1, R2 = H or 1-4C alkyl; Z = 2-6 sugar residues (optionally substituted by up to 6 Me, sugar residue, di-sugar residue, SO2OH, CONR1R2, CO(1-4C alkyl), P(=O)(H)OH, P(=O)(OH)2, P(=S)(H)OH, P(=S)(OH)2, P(=S)(SH)(OH), P(=O)(OH)OCH2CH2NR1R2), or the glycosidic bridge between the 2-6 sugar residues may be 1-6 fold replaced by CH2 or S; R = inositol, inositol phosphate, inositol thiophosphate, inositol cyclo-phosphate, inositol cyclo-thiophosphate (optionally substituted by 1-2 phosphate or thiophosphate, or single substitution by cyclo-phosphate or cyclo-thiophosphate), or inositol (where two neighbouring OH groups are replaced by CH2SO2NH).
-
公开(公告)号:MX9709207A
公开(公告)日:1998-05-31
申请号:MX9709207
申请日:1997-11-27
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER
IPC: C07H15/207 , A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/715 , A61K31/716 , A61K38/28 , A61P3/08 , A61P3/10 , A61P5/00 , A61P5/48 , C07H3/04 , C07H3/06 , C07H11/04 , C07H15/203 , C08B37/00
Abstract: Se describen compuestos de laformula I A - Z - R (I) en la que A representa el resto H-P(O)(OH)-, H-P(S)(OH)-, HO-P(S)(OH)-, HS-p(S)(OH)-, alquilo (C1-C4)-P(O)(OH)-, alquiloC1-C4)-P(S)(OH)-, S(O)2(OR1)-,S(O)(OR1)-, NH2-C(O)-, R1R2N-, R1R2N-C(O)-NH-, R1R2N-C(O)-NH-, R1O-SO2-NH-, alquilo(C1-C4)-SO2-, alquilo(C1C4)-S(O)- o R1-S-, Z representa 2 a 6 restos azucar sustituidos o no sustituidos, y R representa inositol sustituido o no sustituido. Los compuestos de la formula I son adecuados de la Diabetes mellitus o diabetes no dependiente de la insulina.
-
公开(公告)号:ZA9708455B
公开(公告)日:1998-03-20
申请号:ZA9708455
申请日:1997-09-19
Applicant: HOECHST AG
Inventor: MUELLER GUENTER , PREIBISCH GERALD , ERTL JOHANN
IPC: C12N15/09 , A61K38/00 , A61K38/17 , A61K38/22 , A61K45/00 , A61P3/10 , A61P5/50 , C07K14/575 , C07K16/26 , C07K19/00 , C12P21/02 , A61K
CPC classification number: C07K14/5759 , A61K38/00
-
公开(公告)号:ZA9206232B
公开(公告)日:1993-04-28
申请号:ZA9206232
申请日:1992-08-19
Applicant: HOECHST AG
Inventor: MUELLER GUENTER , GUENTER MUELLER , TRIPIER DOMINIQUE , DOMINIQUE TRIPIER , MUELLNER STEFAN , STEFAN MUELLNER
IPC: A61K38/28 , A61K31/715 , A61K38/00 , A61P3/08 , A61P3/10 , C07K1/22 , C07K5/08 , C07K5/093 , C07K5/10 , C07K9/00 , C07K14/37 , C07K14/41 , C07K14/475 , C07K14/575 , C07K14/62 , C07K14/65 , C12P19/26 , C12P21/00 , C12P21/02 , C12R1/865 , C07K
CPC classification number: C07K14/475 , A61K38/00 , C07K5/0827 , C07K5/1027 , C07K9/001 , C12P19/26
-
公开(公告)号:NO924585D0
公开(公告)日:1992-11-27
申请号:NO924585
申请日:1992-11-27
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER , MUELLNER STEFAN , BREIPOHL GERHARD
IPC: A61K38/00 , A61K38/28 , A61P3/08 , A61P3/10 , C07K5/06 , C07K5/065 , C07K5/08 , C07K5/087 , C07K5/093 , C07K5/097 , C07K7/06 , C07K7/08 , C07K9/00 , C07K5/00
Abstract: Peptides with insulin-like activity and the formula I where C is a hydrogen atom, amino-acid residue, substituted amino-acid residue or sugar residue, D is an amino-acid residue, phosphoamino-acid residue, sugar residue, covalent bond or hydroxyl radical, E is a hydrogen atom, hydroxyl radical, substituted sugar residues, substituted alkyldiamine or glycerol residue, R is (C1-C4)-alkyl, =O or -O-(C1-C4)-alkyl, R is a sulphur protective group, SO2, SO3, (C1-C3)-alkyl, O2 radical, O3 radical, or hydrogen atom, R or R is, independently of one another, hydrogen or methyl, and W is an integer 1 or 2, the preparation and use thereof for the treatment of diabetes mellitus or non-insulin-dependent diabetes are described.
-
公开(公告)号:NO914999A
公开(公告)日:1992-06-22
申请号:NO914999
申请日:1991-12-18
Applicant: HOECHST AG
Inventor: MUELLNER STEFAN , KOENIG WOLFGANG , MUELLER GUENTER
-
9.
公开(公告)号:RU2201249C2
公开(公告)日:2003-03-27
申请号:RU99107759
申请日:1997-09-15
Applicant: HOECHST AG
Inventor: MUELLER GUENTER , PREIBISCH GERALD , ERTL JOHANN
-
公开(公告)号:FI105816B
公开(公告)日:2000-10-13
申请号:FI915933
申请日:1991-12-17
Applicant: HOECHST AG
Inventor: MUELLNER STEFAN , KOENIG WOLFGANG , MUELLER GUENTER
IPC: A61K38/00 , A61K38/06 , A61K38/08 , A61K38/28 , A61P3/08 , A61P3/10 , A61P43/00 , C07K1/113 , C07K5/08 , C07K5/087 , C07K5/10 , C07K7/00 , C07K7/06 , C07K14/62
Abstract: Short peptides of the formula I X-Y-A-B-C-Cys-D-E (I> in which A and B are an amino acid or a covalent bond, C and D are an amino acid or a substituted amino acid, E is a modified or unmodified amino acid or a covalent bond, X is a radical or hydrogen and Y is leucine or a covalent bond, or dimers of the peptides of the formula I with cystine as dimerisation component, the stereoisomeric forms thereof where appropriate or their physiologically tolerated salts, the preparation thereof, and their use for the treatment of diabetes mellitus are described.
-
-
-
-
-
-
-
-
-